Customer Support: 131 242

Your region & currency

Australia English(AU)

Pricing in AUD $

Local sites

  • Shopping Cart
    There are no items in your cart

We noticed you are browsing from United States. Switch to our United States site for local pricing in USD.

Dismiss alert
Wiring Rules bundle. AS/NZS 3000 + 3008.1.1 with 10% off already included. Shop Now

I.S. EN ISO 10993-3:2014

Current

Current

The latest, up-to-date edition.

BIOLOGICAL EVALUATION OF MEDICAL DEVICES - PART 3: TESTS FOR GENOTOXICITY, CARCINOGENICITY AND REPRODUCTIVE TOXICITY (ISO 10993-3:2014)

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

01-01-2014

$129.17
Including GST where applicable
Summarise this standard

For Harmonized Standards, check the EU site to confirm that the Standard is cited in the Official Journal.

Only cited Standards give presumption of conformance to New Approach Directives/Regulations.

Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 Requirements for test strategies
5 Genotoxicity tests
6 Carcinogenicity tests
7 Reproductive and developmental toxicity tests
8 Test report
Annex A (informative) - Guidance on selecting an appropriate
        sample preparation procedure in genotoxicity testing
Annex B (informative) - Flowchart for follow-up evaluation
Annex C (informative) - Rationale of test systems
Annex D (informative) - Cell transformation test systems
Annex E (normative) - Considerations for carcinogenicity studies
        performed as implantation studies
Annex F (informative) - In vitro tests for embryo toxicity
Bibliography
Annex ZA (informative) - Relationship between this
         European Standard and the Essential
         Requirements of EU Directive 93/42 EEC
         on medical devices
Annex ZB (informative) - Relationship between this
         European Standard and the Essential
         Requirements of EU Directive 90/385/EEC on
         active implantable medical devices

Describes strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices: - genotoxicity - carcinogenicity, - reproductive and developmental toxicity.

Committee
ISO/TC 194
DevelopmentNote
Supersedes I.S. EN 30993-3 (12/2003)
DocumentType
Standard
Pages
52
PublisherName
National Standards Authority of Ireland
Status
Current
Supersedes

$129.17
Including GST where applicable